Shots:
Erika spoke about the FDA Breakthrough Device Designation received by Abbott to investigate its deep brain stimulation (DBS) system to treat treatment-resistant depression (TRD)
Erika also talked about how NeuroSphere Virtual Clinic is compatible with the deep brain stimulation (DBS) system
The interview gives an understanding of Abbott’s vision to bring life-changing technologies in…
